Zeria Pharmaceutical Co., Ltd. (4559.T)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap106.49B
EV106.49B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
TTM
Revenue
462.2
455.3
465.9
483.6
481.5
461.0
450.6
413.3
443.9
493.3
Revenue % Chg.
16.3%
-1.5%
2.3%
3.8%
-0.4%
-4.3%
-2.2%
-8.3%
7.4%
13.7%
Cost of Revenue
136.8
138.1
133.7
135.5
136.8
132.4
124.1
117.8
129.6
138.6
Gross Profit
325.4
317.2
332.2
348.1
344.8
328.6
326.5
295.5
314.3
354.7
Gross Profit Margin
70.4%
69.7%
71.3%
72.0%
71.6%
71.3%
72.5%
71.5%
70.8%
71.9%
Other Expenses
274.8
297.2
298.1
314.3
308.7
300.7
296.0
269.9
266.8
284.5
Operating Income
50.6
20.0
34.0
33.9
36.0
27.9
30.5
25.7
47.5
70.2
Operating Income Margin
11.0%
4.4%
7.3%
7.0%
7.5%
6.0%
6.8%
6.2%
10.7%
14.2%
Total Other Income/Expenses Net
3.9
8.5
5.2
2.8
5.6
11.1
-1.3
3.6
-4.8
-19.3
Income Before Tax
54.5
28.5
39.2
36.7
41.6
38.9
29.2
29.3
42.7
51.0
Income Before Tax Margin
11.8%
6.3%
8.4%
7.6%
8.6%
8.4%
6.5%
7.1%
9.6%
10.3%
Income Tax Expense
15.2
9.4
12.9
10.0
10.4
13.1
7.3
5.9
13.0
6.8
Net Income
39.3
19.1
26.2
26.4
31.0
25.8
21.8
23.3
29.5
44.0
Net Income Margin
8.5%
4.2%
5.6%
5.5%
6.4%
5.6%
4.8%
5.6%
6.7%
8.9%
Weighted Avg. Shares Out
45.9
53.1
53.1
53.1
51.5
49.7
46.7
46.1
45.1
44.6
EPS
0.9
0.4
0.5
0.5
0.6
0.5
0.5
0.5
0.7
1.0
EPS % Chg.
31.3%
-58.1%
37.4%
0.9%
21.0%
-13.8%
-10.0%
8.9%
28.6%
74.8%
Weighted Avg. Shares Out Dil
45.9
53.1
53.1
53.1
51.5
49.7
46.7
46.1
45.1
44.6
EPS Diluted
0.9
0.4
0.5
0.5
0.6
0.5
0.5
0.5
0.7
1.0
Interest Income
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.3
Interest Expense
1.8
1.5
2.2
2.0
1.5
1.5
1.7
1.8
2.4
2.6
EBIT
52.8
27.1
37.2
34.8
40.2
37.5
27.6
27.7
40.4
48.7
EBIT Margin
11.4%
5.9%
8.0%
7.2%
8.3%
8.1%
6.1%
6.7%
9.1%
9.9%
Depreciation & Amortization
19.6
20.2
23.3
28.3
28.6
27.8
30.1
32.9
39.4
-13.4
EBITDA
72.4
47.3
60.5
63.0
68.8
65.4
57.8
60.6
79.9
35.3
EBITDA Margin
15.7%
10.4%
13.0%
13.0%
14.3%
14.2%
12.8%
14.7%
18.0%
7.2%